Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Näky vs Ozari Health

Näky
Graded #394

Lower grade

vs+11.300000000000004
Ozari Health
Graded #136

Higher grade

The verdict

Ozari Health takes it — 68.9/100 to 57.6/100.

Ozari Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ozari Health is a telehealth weight-loss platform selling physician-prescribed compounded GLP-1 from licensed 503A/503B pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOzari Health +30
45
75
Dose & formulationOzari Health +13
51
64
Clinical oversightOzari Health +3
76
79
Labs & monitoringEven
52
52
FulfillmentOzari Health +10
73
83
Contract termsNäky +8
55
47
Näky · left barOzari Health · right bar

The numbers

MetricNäkyOzari Health
WeighScore57.6/10068.9/100
GradeCC
Scorecard rank#394#136
SemaglutideNot disclosed$86/mo (3-mo starter plan, new patients only, compounded)
TirzepatideNot disclosed$125/mo (3-mo starter plan, new patients only, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Näky

Graded #394 · C

Strengths

  • LegitScript Approved (verifiable for benaky.com)
  • Oral semaglutide drops as a distinct product line — uncommon among compounded GLP-1 brands
  • Separate GLP-1 microdose program offered
  • Adds NAD+ and Sermorelin for patients wanting a longevity stack
  • 3-minute online assessment with a same-day treatment plan

Where it loses points

  • Ongoing monthly pricing for compounded semaglutide and tirzepatide isn't shown until intake
  • Oral semaglutide drops and microdose program pricing not disclosed
  • Legal entity and state of incorporation not disclosed
  • Pharmacy partner not named — only a generic 'USA-based FDA-regulated' claim
  • States served not listed; pricing pages return 404s
Ozari Health

Graded #136 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
  • Cancelling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard